Stephen Juvet

Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.

Rare lung diseases I--Lymphangioleiomyomatosis.

Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans.

Rare lung disease II: pulmonary alveolar proteinosis.

Prostaglandin E2 signaling through E prostanoid receptor 2 impairs proliferative response of double negative regulatory T cells.

Rare lung diseases III: pulmonary Langerhans' cell histiocytosis.

Regulation of antigen-expressing dendritic cells by double negative regulatory T cells.

Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions.

Autocrine IFNγ controls the regulatory function of lymphoproliferative double negative T cells.

FcRγ promotes T cell apoptosis in Fas-deficient mice.

Rejection of tracheal allograft by intrapulmonary lymphoid neogenesis in the absence of secondary lymphoid organs.

FcRγ controls the fas-dependent regulatory function of lymphoproliferative double negative T cells.

Halofuginone treatment reduces interleukin-17A and ameliorates features of chronic lung allograft dysfunction in a mouse orthotopic lung transplant model.

Safety and Efficacy of Ex Vivo Donor Lung Adenoviral IL-10 Gene Therapy in a Large Animal Lung Transplant Survival Model.

Syk Regulates Neutrophilic Airway Hyper-Responsiveness in a Chronic Mouse Model of Allergic Airways Inflammation.

Higher M30 and high mobility group box 1 protein levels in ex vivo lung perfusate are associated with primary graft dysfunction after human lung transplantation.

Pentraxin 3 deficiency enhances features of chronic rejection in a mouse orthotopic lung transplantation model.

Sequential broncho-alveolar lavages reflect distinct pulmonary compartments: clinical and research implications in lung transplantation.

A novel combined ex vivo and in vivo lentiviral interleukin-10 gene delivery strategy at the time of transplantation decreases chronic lung allograft rejection in mice.

Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.

Neutrophil extracellular traps in lung perfusion perfusate predict the clinical outcome of lung transplant recipients.

Lentiviral interleukin-10 gene therapy: Safety and questions.

Cytokine profile in lung transplant recipients with Aspergillus spp colonization.

Molecular assessment of rejection and injury in lung transplant biopsies.

Innate Control of Tissue-Reparative Human Regulatory T Cells.

Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort study.

Donor human leukocyte antigen-G single nucleotide polymorphisms are associated with post-lung transplant mortality.

A B cell-dependent pathway drives chronic lung allograft rejection after ischemia-reperfusion injury in mice.

The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation.

Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation.

DNase to the Rescue! Clearing Mitochondrial DNA May Have NET Benefits in Lung Transplantation.

The role of innate immunity in the long-term outcome of lung transplantation.

Extracellular Matrix Injury of Kidney Allografts in Antibody-Mediated Rejection: A Proteomics Study.

Evaluation of Recombinant Herpes Zoster Vaccine for Primary Immunization of Varicella-seronegative Transplant Recipients.

Safety and immunogenicity of adjuvanted recombinant subunit herpes zoster vaccine in lung transplant recipients.

Lung transplantation for late-onset non-infectious chronic pulmonary complications of allogenic hematopoietic stem cell transplant.

Autologous Hematopoietic Stem Cell Transplantation for Liver Transplant Recipients With Recurrent Primary Sclerosing Cholangitis: A Pilot Study.

Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.

delivery of regulatory T-cells for control of alloimmune priming in the donor lung.

Recipient bone marrow-derived IL-17 receptor A-positive cells drive allograft fibrosis in a mouse intrapulmonary tracheal transplantation model.

Engineered mesenchymal stromal cell therapy during human lung lung perfusion is compromised by acidic lung microenvironment.

Transcripts associated with chronic lung allograft dysfunction in transbronchial biopsies of lung transplants.

Evaluation of a gene expression biomarker to identify operationally tolerant liver transplant recipients: the LITMUS trial.

Interferon-stimulated and metallothionein-expressing macrophages are associated with acute and chronic allograft dysfunction after lung transplantation.

A biomarker assay to risk-stratify patients with symptoms of respiratory tract infection.

The molecular features of chronic lung allograft dysfunction in lung transplant airway mucosa.

Donor and recipient human leukocyte antigen-G polymorphisms modulate the risk of adverse immunologic events following lung transplantation.

Donor Batf3 inhibits murine lung allograft rejection and airway fibrosis.

Immunohistochemical Analysis of Lymphocyte Populations in Acute Skin Rejection: The University Health Network Addition to the Banff Classification.

Congenic hematopoietic stem cell transplantation promotes survival of heart allografts in murine models of acute and chronic rejection.

Alpha-1-antitrypsin safely promotes rapid recovery of pigs after lung transplantation.

Defining a natural killer cell-enriched molecular rejection-like state in lung transplant transbronchial biopsies.

Immunomodulation of the donor lung with CRISPR-mediated activation of IL-10 expression.

A Novel Tissue Preservation and Transport Solution as a Substitute for Formalin.

Donor IL-17 receptor A regulates LPS-potentiated acute and chronic murine lung allograft rejection.